Close menu




January 3rd, 2025 | 07:00 CET

D-Wave Quantum, ARI Motors, Bayer – Which stocks should be in the portfolio for 2025?

  • Electromobility
  • Pharma
  • Software
  • Technology
Photo credits: pixabay.com

After Google presented its quantum processor, Willow, D-Wave Quantum's shares skyrocketed. The question is how sustainable this increase is and whether quantum computing will be the next big hype after artificial intelligence. For the automotive industry, 2024 was a year to forget. Many automakers are currently struggling with problems. ARI Motors, an electric vehicle manufacturer that has secured a niche for itself, is faring better. Will the entire automotive industry manage a turnaround in the coming year? Bayer's shareholders are also hoping for a turnaround. The share price took a significant hit last year. 2025 is expected to be much better. We take a closer look at the individual stocks.

time to read: 5 minutes | Author: Armin Schulz
ISIN: D-WAVE QUANTUM INC | US26740W1099 , ARI MOTORS INDUSTRIES SE | DE000A3D6Q45 , BAYER AG NA O.N. | DE000BAY0017

Table of contents:


    Uwe Ahrens, Director, Altech Advanced Materials AG
    "[...] We know exactly what we are doing and are implementing what we consider to be a proven technology in an industrially applicable and scalable way. [...]" Uwe Ahrens, Director, Altech Advanced Materials AG

    Full interview

     

    D-Wave Quantum – Holds numerous patents

    With Google's Willow quantum chip, second-tier companies working on quantum computing have come into focus. Their stocks have skyrocketed, including that of D-Wave Quantum. The Company boasts the third-largest quantum patent portfolio in the world and thus clearly stands out from the competition. The business model is based on a "Quantum Computing-as-a-Service" platform and is intended for commercial use. This service is becoming increasingly popular, and revenues have recently risen accordingly. However, as of 2024, total revenues have yet to exceed USD 10 million.

    From a financial point of view, D-Wave Quantum is in a tight spot. The ratio of long-term debt to capital is over 103%, and its credit rating is not that great either. Added to this is the high cash burn rate. Revenues are not even reaching USD 10 million a year, but losses in the last quarter alone were a whopping USD 57 million. Cash on hand at the end of the third quarter was USD 29 million. Accordingly, the Company took advantage of the bull market and raised USD 75 million in December. A significant improvement in operating costs, in particular, is expected in the coming months.

    The market for quantum computing currently offers tremendous opportunities, and D-Wave Quantum could benefit from them in the long term, provided it does not run out of money first. If we compare some key figures with those of the peer group, the value of the share is below that of its competitors. This is likely due to the tense financial situation. Nevertheless, D-Wave could have a future due to its technical innovations, patent base, and growing user base. Nevertheless, investors should act with caution here. The share is currently trading at USD 8.40.

    ARI Motors – Successful in a niche market

    In the long term, there is no stopping electric mobility. Advances in battery technology will have a positive impact on costs, range and charging times. In addition, solid-state batteries will be safer than the current generation of batteries. Furthermore, the charging infrastructure is being expanded, which will further increase the vehicles' suitability for everyday use. If the forecasts that battery costs will fall by around 40% are accurate, this should also reduce the prices of electric vehicles. ARI Motors already offers affordable electric vehicles and has established itself in the niche market for light commercial vehicles. The Company caters specifically to the wishes of its customers and now has over 50 variants in its program.

    In the future, however, the Company also wants to appeal to private motorists and has developed an affordable, environmentally friendly electric vehicle for urban areas for this purpose. The ARI Bruni is available from EUR 15,990, has a top speed of 90 km/h, offers space for 4 people and that at a size of 3.07 m long and 1.49 m wide. With the rear seat folded down, the city runabout has a boot volume of 1,180 litres. This makes it particularly suitable for city driving, and it can fit into the smallest of parking spaces. The range is 215 km, and the vehicle can be fully charged in 4-5 hours. The quick-charge function can charge the vehicle from 30% to 80% in 35 minutes. For the city, it is a real alternative to conventional vehicles.

    In 2024, managing director Thomas Kuwatsch stated that more than 250 vehicles will be delivered, corresponding to a turnover of around EUR 6 million. At the beginning of December, 264 vehicles had been pre-ordered. All this is achieved through an online shop and word-of-mouth advertising. Now, 12 commercial vehicle dealers and 6 dealers in the standard passenger vehicle sector also offer the vehicles. If the forecasts are correct and the market for electric vehicles continues to grow in 2025, ARI Motors will get a slice of the pie with its affordable, environmentally friendly vehicles suitable for everyday use. After reaching a high of EUR 0.57, the share price fell and has now repeatedly tested the EUR 0.36 mark. An interesting hammer candlestick was observed on December 30. The closing price in Frankfurt was EUR 0.38.

    Bayer – The situation is clear

    Last year was a challenging one for Bayer shareholders. The Company is struggling with a multitude of problems. The agriculture business suffered from low demand. In addition, lower fertiliser prices weighed further on the figures. In the third quarter, the Leverkusen-based company had to make write-offs, which contributed significantly to the net loss of around EUR 4.2 billion. The debt of around EUR 35 billion, which is mainly due to the Monsanto acquisition, also left little room for manoeuvre. This acquisition has also given rise to the ongoing legal disputes surrounding glyphosate.

    To counter these problems, management has begun to take countermeasures to stabilise the situation. In the pharmaceuticals business, there are positive developments with Nubeqa™ and Kerendia™, so the expired patents of blockbusters such as Xarelto™ and Eylea™ are not quite as significant. However, they are not yet able to fully compensate for the sales. A savings program is expected to help save EUR 2 billion annually from 2026. The Company hopes to become more efficient by streamlining its organisation. The dividend has also been reduced to a minimum in order to push ahead with debt reduction. There have also been rumors of a capital increase of EUR 5 billion, but this has not yet been confirmed.

    CEO Bill Anderson expressed satisfaction with the progress made so far. By the end of 2024, 80 to 90% of the teams are to be working according to the new organizational model, a target originally planned for fall 2025. It now remains to be seen whether the focus on growth markets and innovations will bear fruit. In addition, it would be desirable for the Company to settle the legal disputes in the US, which would provide greater planning security. If debt reduction also progresses, the Company will regain more financial flexibility. Most analysts recommend holding the stock with price targets between EUR 22 and 30. Currently, the share is trading at EUR 19.31, and a double bottom has been formed at EUR 18.57.


    D-Wave Quantum is well positioned with its strong patent portfolio and "Quantum Computing-as-a-Service" platform, but is on shaky ground due to high losses and financial problems. ARI Motors has secured a niche market with affordable, environmentally friendly electric vehicles and plans to continue to make inroads with private customers. Bayer is working on a turnaround despite high debts and legal disputes and has introduced austerity measures to gain room to manoeuvre.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Armin Schulz

    Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.

    About the author



    Related comments:

    Commented by André Will-Laudien on September 9th, 2025 | 10:05 CEST

    The next wave is coming! NetraMark and BioNTech are on the winning track - Can Novo Nordisk and Eli Lilly follow suit?

    • Biotechnology
    • Biotech
    • Pharma

    Artificial intelligence (AI) is transforming the development of new drugs by analyzing complex data at lightning speed and making clinical trials more efficient. AI technologies enable candidates to be selected more specifically for research projects and therapeutic successes to be predicted with greater precision. Companies such as NetraMark and BioNTech have already successfully used these tools, with the Mainz-based company currently even achieving breakthroughs in oncology. Meanwhile, Novo Nordisk and Eli Lilly, once stars of the obesity market, are now seen as "fallen angels". Will they manage to turn things around? Investors with foresight now have new opportunities in rapidly growing billion-dollar markets. A long-awaited interest rate cut in the US could be the spark the sector needs! Selection is now key!

    Read

    Commented by Armin Schulz on September 9th, 2025 | 07:25 CEST

    From ore to energy: How BYD, Power Metallic Mines, and Siemens Energy are benefiting from the energy transition

    • Mining
    • Nickel
    • Copper
    • RareEarths
    • Electromobility
    • renewableenergies
    • Energy

    The global energy transition is not only sparking hope but also a race for scarce raw materials. Nickel, cobalt, copper, lithium, and rare earths are becoming the backbone of batteries and wind turbines, while geopolitical tensions over supply chains are driving up prices. Those who position themselves in time could benefit from the redistribution of global power. This is particularly exciting for companies that either secure access to these resources, develop technologies for their use, or play a decisive role in the value chain, such as BYD, Power Metallic Mines, and Siemens Energy.

    Read

    Commented by Nico Popp on September 9th, 2025 | 07:15 CEST

    MENA region offers growth opportunities: What can MiMedia learn from Anghami and Thomson Reuters?

    • cloud
    • Digitization
    • Streaming
    • Technology
    • Software

    Regional opportunities on the stock market still exist: The Arabic-speaking countries of the Middle East and North Africa (MENA region) are among the most dynamic growth markets for digital services. A rapidly growing, young population with increasing smartphone penetration is driving demand for cloud services, streaming offerings, and digital information. MarkNtel Advisors forecasts annual growth rates of 18% for cloud solutions in the MENA region through 2028. White-label cloud provider MiMedia has just rolled out its app in Arabic and anticipates significant growth. Role models could be the streaming platform Anghami and the data service provider Thomson Reuters, which have already discovered the region for themselves.

    Read